Navigation Links
Study details how protein made by HPV teams up on and thwarts protective human protein
Date:1/11/2011

BETHESDA, Md., Jan. 11, 2011 An international team of researchers is reporting that it has uncovered new information about human papillomavirus that one day may aid in the development of drugs to eliminate the cervical-cancer-causing infection.

Led by researcher Per Jemth of Uppsala University in Sweden, the collaborators from four institutions detail in the Journal of Biological Chemistry how an offensive protein generated by the sexually transmitted virus handicaps a defensive protein made by the human body.

Co-author Neil Ferguson, a biophysicist at University College Dublin, says: "It has proved difficult to stem the proliferation of many viruses using conventional drug discovery. Inhibitors of protein-protein interactions, as in HPV's case, are potentially potent ways to perturb viral infections."

There are almost 200 strains of HPV, dozens of which are transmitted through genital contact, and about half of sexually active people have had one or more infections.

The immune system eliminates the virus within two years in about 90 percent of cases, according to the Centers for Disease Control and Prevention in Atlanta, but it lingers for many years in a minority of cases. Some strains result in no visible symptoms, others cause genital warts and still others cause cancer.

"Infection by high-risk human papillomaviruses is causing as many as half a million cases of cervical cancer and more than 200,000 deaths among women per year, making it one of the most common forms of cancer," Jemth emphasized.

For the virus to replicate, it has to interfere with the body's natural inclination to kill infected cells.

What is known as "programmed cell death," or the destruction of sick cells, ordinarily is carried out by several human proteins. However, when HPV is present, the virus sends out two of its own assassin proteins, known as E6 and E7, to stop the defensive human proteins in their tracks.

"Why is the virus causing cancer? In rare cases, the HPV infection is not cleared by the immune system and persists for decades. The virus' release of E6 and E7 proteins then increases the risk of deterioration to cancer by causing cell proliferation and preventing programmed cell death," explains Jemth. "If the cell dies, the virus will die along with it. So, the virus sends out these gunmen to assassinate proteins made by the body -- a hostile takeover, if you like."

In its study, Jemth's team offers a detailed look at how one human protein in particular, SAP97, is targeted by HPV assassin E6.

"To develop antivirals that prevent protein-protein interactions, in this case those of E6 and human proteins, it is necessary to first understand the biomolecular interactions required for virus viability and, where relevant, exploit these insights," says Ferguson.

So, the team used different techniques to visualize the attack or, rather, how HPV's E6 and man's SAP97 bind to each other.

"We studied how fast E6 is latching onto SAP97, how fast it is coming off, how strongly it holds onto SAP97, and what happens to the shape of SAP97 as E6 is attached to it," says Celestine Chi, the first author of the paper.

It turns out that there are three places on SAP97 where HPV's E6 can latch on, he says, which bogs down the human protein so that it cannot carry out its normal function.

In fact, the team reports, three E6 molecules can attach to one SAP97 molecule simultaneously essentially teaming up on the protein.

There currently are two vaccines that prevent HPV infection on the market, Cervarix and Gardasil, but they do nothing for those people who already are infected.

"Fundamental research on HPV is, therefore, still necessary to discover new routes to cure infection," Jemth says, which is why the team intends to continue its investigation and now has its crosshairs on HPV's E7 protein.

Ferguson adds: "The team's work represents an important step forward in understanding HPV biology and has important implications for therapeutic strategies. What was nice about this collaboration is that multiple laboratories worked synergistically such that the scope of the research and strength of the conclusions were significantly increased."


'/>"/>

Contact: Angela Hopp
ahopp@asbmb.org
301-634-7389
American Society for Biochemistry and Molecular Biology
Source:Eurekalert  

Related medicine news :

1. Private Rooms Cut Infection Risk in the ICU: Study
2. Closely Spaced Pregnancies Might Up Autism Risk: Study
3. U.S. Nursing Home Closings Hit Poor Neighborhoods Hardest: Study
4. Case Western Reserve University School of Medicine launches the National Childrens Study
5. Spanish heart risk study challenges image of healthy Mediterranean diet and lifestyle
6. Study Refutes Myth That Eating Disorders Affect Whites Only
7. Many Survivors of World Trade Center Attacks Suffered PTSD: Study
8. Study shows promise for new drug to treat Fragile X
9. Age Takes Toll on Facial Bones, Study Finds
10. Circumcision Helps Cut HPV Transmission Rate, Study Finds
11. Liver disease a possible predictor of stroke: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study details how protein made by HPV teams up on and thwarts protective human protein
(Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as ... production of the series is on hiking in American. Viewers can reconnect with America ... great benefits of hiking. , Many consumers have looked for an inventive new place ...
(Date:5/26/2017)... ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the personal journey of ... Cross” is the creation of published authors, Bob and Margaret Massey. Bob Massey is ... is "panther quick and leather tough." His love for others is apparent in all ...
(Date:5/26/2017)... ... ... Jack: Against All Odds”: the story of Coach Cactus Jack and the impact he ... creation of published author, Walter Hubbard, a retired wildlife and fisheries biologist and pharmacy ... Walter and Jane have three adult children and a granddaughter. Walter and ...
(Date:5/24/2017)... ... May 24, 2017 , ... In ... choosing the most appropriate instruments for research and understanding the basic principles that ... webinar will focus on innovations in stereo microscopy for brightfield and fluorescence typically ...
(Date:5/24/2017)... California (PRWEB) , ... May 24, 2017 , ... ... through innovative medical image management and interpretation, has received U.S. Food and Drug ... , Nucleus.io is a web-based, scalable and secure cloud platform for medical image ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading healthcare data analytics ... 2017 ranking of the Best-Equipped Hospitals in Latin America ... GHI,s hospitals database for Latin America , which is ... database covers 86% of the hospitals in Latin ... each institution in key areas such as beds, medical specialties, ...
(Date:5/9/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... has earned a spot on Forbes, "America,s ... ranked among 500 U.S. employers as well as in ... Services. The annual Forbes rankings ... of over 30,000 employees across 25 industries. The survey ...
Breaking Medicine Technology: